U&U Plastic Surgery
Coverage of breast surgery, screening, and aftercare, with clinic facts verified against U&U Plastic Surgery's official website.
External links are provided to verify the clinic's own information. A profile does not imply partnership, endorsement, or article review.
These clinicians are listed on the clinic's official website. Unless explicitly stated, they did not write or clinically review MediIndex articles.
A UCLA Health Jonsson Comprehensive Cancer Center-led study found that an oxaloacetate supplement may improve cognitive function and reduce fatigue in some breast cancer survivors after treatment.
MSD Korea highlighted Keytruda’s treatment evidence across early-stage and metastatic triple-negative breast cancer during Breast Cancer Awareness Month.
World Breast Cancer Day on October 19 renewed attention to regular screening, early detection and risk-based management of breast cancer.
Researchers conducting a Finnish registry study found that poor oral health increased the risk of jawbone necrosis among breast cancer patients receiving antiresorptive treatment.
Employees of Marken Korea and GE HealthCare Korea joined the 2026 Pink Run in Seoul to raise awareness of breast cancer prevention and breast health.
The FDA approved Tukysa with trastuzumab and pertuzumab as maintenance therapy after induction treatment for adults with unresectable locally advanced or metastatic HER2-positive breast cancer.
Some patients with breast cancer can undergo surgery that removes the tumor and nearby tissue while preserving as much normal breast tissue as possible, depending on the tumor’s size, location, and stage.
Researchers linked exercise with better attention among breast cancer survivors who may experience lasting cognitive difficulties.
The team behind a large U.S. insurance claims analysis found that many patients with early-stage breast cancer did not consistently continue prescribed long-term endocrine therapy after lumpectomy.
The FDA approved Eli Lilly’s Inluriyo and Verzenio combination for certain adults with advanced or metastatic ER-positive, HER2-negative breast cancer carrying an ESR1 mutation.
The FDA granted accelerated approval to AstraZeneca's camizestrant for certain adults with advanced or metastatic HR-positive, HER2-negative breast cancer whose ESR1 mutation is detected during treatment through an FDA-approved test.
A British Heart Foundation-funded study suggests that many breast cancer survivors with treatment-related heart-function problems may safely stop heart medication after recovery.
Breast Augmentation Timing, Pregnancy and Nursing — 26 reader questions, each answered in full with the caveats that matter.
Before Breast Augmentation: Tests and Medications — 26 reader questions, each answered in full with the caveats that matter.
Breast Augmentation Early Recovery — 26 reader questions, each answered in full with the caveats that matter.
Returning to Exercise After Breast Augmentation — 26 reader questions, each answered in full with the caveats that matter.
Warning Signs After Breast Augmentation — 26 reader questions, each answered in full with the caveats that matter.
Breast Implant Follow-Up and Imaging — 26 reader questions, each answered in full with the caveats that matter.
Where the incision goes shapes how visible the scar is, how directly the surgeon can work, and whether the same route can be reused later.
Breast augmentation planning turns less on any single product and more on how surface texture, gel cohesiveness, incision site and implant plane fit an individual body.
Rebuilding movement after breast surgery works in phases — gentle range-of-motion first, posture work next, and loaded training only after the chest has settled.
Whether an implant sits under the muscle, under its fascia or in a dual-plane pocket changes coverage, movement and how the breast reads on imaging.
Scar care after breast surgery is less about a single product and more about matching the right tool — taping, silicone, sun protection — to each stage of healing.
Some difference between breasts is the rule rather than the exception, and surgery becomes a conversation only when the gap is pronounced or distressing.
Implants change how breast imaging is done, not whether it should be done — and each modality answers a different question.
The bra worn after breast surgery is part of the treatment plan — compression timing, underwire restrictions and proper fitting all change as healing progresses.
The smallest procedures in breast surgery target the nipple and areola, where millimeters of change carry outsized weight for function and confidence.
Macromastia can drive a recognizable pattern of shoulder grooving, neck and back pain and skin irritation — and knowing the pattern helps decide when to seek evaluation.
The weeks before breast surgery are a structured screening process — lab tests, baseline imaging and sizing sessions — designed to catch problems while they are still easy to address.
Breast surgery recovery works in stages — graded activity, supportive garments, gentle physiotherapy and early scar care each have their moment.
Mastopexy is not one operation but a spectrum of incision patterns, and the degree of sagging largely decides which one a surgeon recommends.
Breast implants come with a follow-up calendar that runs for as long as the devices do, from early wound checks to imaging that recurs every few years.
Augmentation, reduction and lift each interact differently with the milk-making system, and incision choices made years earlier can shape a future nursing experience.
Reduction and mastopexy sit where symptom relief meets aesthetics, and honest planning means weighing sensation, breastfeeding and scars up front.
